Top

Clinical Reviews in Allergy & Immunology

Published in:

18-09-2021 | Public Health

Public Health Measures and the Control of COVID-19 in China

Authors: Zhangkai Jason Cheng, Zhiqing Zhan, Mingshan Xue, Peiyan Zheng, Jiali Lyu, Jing Ma, Xiaohua Douglas Zhang, Wenting Luo, Huimin Huang, Yong Zhang, Hongman Wang, Nanshan Zhong, Baoqing Sun

Published in: Clinical Reviews in Allergy & Immunology | Issue 1/2023

Abstract

In December 2019, the COVID-19 pandemic quickly spread throughout China and beyond, posing enormous global challenges. With prompt, vigorous, and coordinated control measures, mainland China contained the spread of the epidemic within two months and halted the epidemic in three months. Aggressive containment strategy, hierarchical management, rational reallocation of resources, efficient contact tracing, and voluntary cooperation of Chinese citizens contributed to the rapid and efficient control of the epidemic, thus promoting the rapid recovery of the Chinese economy. This review summarizes China’s prevention and control strategies and other public health measures, which may provide a reference for the epidemic control in other countries.

Cheng ZJ, Shan J (2020) 2019 Novel coronavirus: where we are and what we know. Infection 48(2):155–163. https://doi.org/10.1007/s15010-020-01401-y CrossRef

China's action against COVID-19 (2020) The state council information office of the people’s republic of china. http://www.gov.cn/zhengce/2020-06/07/content_5517737.htm. Accessed 20 August 2021

Zhao J, Yuan Q, Wang H et al (2020) Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis 71(16):2027–2034. https://doi.org/10.1093/cid/ciaa344 CrossRef

Ren LL, Wang YM, Wu ZQ et al (2020) Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl) 133(9):1015–1024. https://doi.org/10.1097/CM9.0000000000000722 CrossRef

Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention (2020) The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 41(2):145–151. https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003 CrossRef

Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273. https://doi.org/10.1038/s41586-020-2012-7 CrossRef

Mei C, Ding P (2020) Ministry of National Defense of the People's Republic of China. Nearly 3,000 beds have been set up in the army, and more than 10,000 medical staff have been sent to the front line for treatment. http://www.mod.gov.cn/topnews/2020-03/03/content_4861388.htm. Accessed 20 August 2021

Zhu Y (2020) The Central Committee of the Communist Party of China and the State Council of China. National Health Commission: Coordinated arrangements for 19 provincial counterparts to support 16 cities and counties in Hubei except Wuhan. http://www.gov.cn/xinwen/2020-02/11/content_5477116.htm. Accessed 20 August 2021

Han W, Zhu M, Chen J, Zhang J, Zhu S, Li T, Cai H, Fang Q, Wei G, Liang T (2020) Lung transplantation for elderly patients with end-stage COVID-19 pneumonia. Ann Surg 272(1):e33–e34. https://doi.org/10.1097/SLA.0000000000003955 CrossRef

10.

Xinhua Net (2020) First in the world! Coronal lung transplant patient discharged from hospital! https://baijiahao.baidu.com/s?id=1672806092125471877&wfr=spider&for=pc. Accessed 20 August 2021

11.

Civil Aviation Administration of China (2020) Civil Aviation Administration adjusts international passenger flight circuit breaker measures http://www.caac.gov.cn/XXGK/XXGK/TZTG/202012/t20201216_205607.html. Accessed 20 August 2021

12.

Beijing News (2020) Over the past year, civil aviation has fused 302 flights, and it is expected to reduce the number of imported cases by more than 2300 https://www.sohu.com/a/481205197_114988. Accessed 20 August 2021

13.

Civil Aviation Administration of China (2020) Technical guidelines for epidemic prevention and control at transport airports (Seventh Edition) http://www.gov.cn/xinwen/2021-02/09/5586231/files/03ea2343f9d444a38a4f1874b37e935d.pdf. Accessed 20 August 2021

14.

Beijing News (2020) Nanjing: all-round closure management of Lukou Airport https://baijiahao.baidu.com/s?id=1706364939027534812&wfr=spider&for=pc. Accessed 20 August 2021

15.

Lu R, Zhao X, Li J et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565–574. https://doi.org/10.1016/S0140-6736(20)30251-8 CrossRef

16.

Bian XW (2020) COVID-19 Pathology Team. Autopsy of COVID-19 patients in China. Natl Sci Rev 7(9):1414–1418. https://doi.org/10.1093/nsr/nwaa123

17.

General Office of the National Health Commission (2021) Notice on the issuance of the COVID-19 protocol (trial eighth revision). http://www.gov.cn/zhengce/zhengceku/2020-08/19/5535757/files/da89edf7cc9244fbb34ecf6c61df40bf.pdf. Accessed 20 August 2021

18.

China Daily (2020) The Second COVID-19 Multidisciplinary Forum on Global Fight Against Epidemic. https://baijiahao.baidu.com/s?id=1662463496587959831&wfr=spider&for=pc. Accessed 20 August 2021

19.

Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q, Deshpande R, Zhang L, Meng J, Tong C, Liu H, Xiong L (2020) Intubation and ventilation amid the COVID-19 outbreak: Wuhan’s experience. Anesthesiology 132(6):1317–1332. https://doi.org/10.1097/ALN.0000000000003296 CrossRef

20.

Ma X, Liang M, Ding M, Liu W, Ma H, Zhou X, Ren H (2020) Extracorporeal membrane oxygenation (ECMO) in critically ill patients with coronavirus disease 2019 (COVID-19) pneumonia and acute respiratory distress syndrome (ARDS). Med Sci Monit 26:e925364. https://doi.org/10.12659/MSM.925364 CrossRef

21.

National Medical Products Administration (2021) https://www.nmpa.gov.cn/. Accessed 20 August 2021

22.

Xinhua (2021) 22 COVID-19 vaccines enter clinical trials in China: health official. https://www.chinadaily.com.cn/a/202107/08/WS60e6e34da310efa1bd660a6f.html. Accessed 20 August 2021

23.

Chinese Clinical Trial Registry (2021) A global, multi-center, randomized, double-blind, placebo-controlled, phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of SARS-CoV-2 mRNA vaccine in population aged 18 years and older. https://www.chictr.org.cn/showproj.aspx?proj=130672. Accessed 20 August 2021

24.

National Health Commission of the People's Republic of China (2021) Novel coronavirus vaccine inoculation. http://www.nhc.gov.cn/jkj/s7915/202108/afb009eb54eb4fff86c9d9595ecb74f3.shtml. Accessed 20 August 2021

25.

Nakamoto I, Wang S, Guo Y, Zhuang W (2020) A QR code-based contact tracing framework for sustainable containment of COVID-19: evaluation of an approach to assist the return to normal activity. JMIR Mhealth Uhealth 8(9):e22321. https://doi.org/10.2196/22321 CrossRef

26.

Boulos MNK, Geraghty EM (2020) Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics. Int J Health Geogr 19(1):8. https://doi.org/10.1186/s12942-020-00202-8 CrossRef

27.

People's Daily Online (2020) Investigation report of health code. https://baijiahao.baidu.com/s?id=1677590328357483692&wfr=spider&for=pc. Accessed 20 August 2021

28.

Sina News (2021) First anniversary report of the health code. http://k.sina.com.cn/article_5787187353_158f17899020017ma9.html. Accessed 20 August 2021

29.

Tai L, Wong K, Wang L, Di LJ (2020) From impossible to possible: the lessons from the control of recent COVID-19 outbreaks in China. Int J Biol Sci 17(6):1600–1612. https://doi.org/10.7150/ijbs.58906 CrossRef

30.

CCTV news (2021) Guangzhou has invested 60000 police to stop the spread of the epidemic. https://www.sohu.com/a/474011252_162522. Accessed 20 August 2021

31.

Xiong Y, Wang Y, Chen F, Zhu M (2020) Spatial statistics and influencing factors of the COVID-19 epidemic at both prefecture and county levels in Hubei Province, China. Int J Environ Res Public Health 17(11):3903. https://doi.org/10.3390/ijerph17113903 CrossRef

32.

Xu T, Yang R (2020) COVID-19 Epidemic and public health measures in China. J Epidemiol Glob Health 10(2):118–123. https://doi.org/10.2991/jegh.k.200421.001 CrossRef

33.

Kickbusch I, Leung G (2020) Response to the emerging novel coronavirus outbreak. BMJ 368:m406. https://doi.org/10.1136/bmj.m406 CrossRef

34.

Tian H, Liu Y, Li Y et al (2020) An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science 368(6491):638–642. https://doi.org/10.1126/science.abb6105 CrossRef

35.

Xinhua Net (2020) Wuhan makeshift hospital expanded to 12 planned to open more than 20,000 beds. http://www.xinhuanet.com/2020-02/19/c_1125596243.htm. Accessed 20 August 2021

36.

Liu W, Guan WJ, Zhong NS (2020) Strategies and advances in combating COVID-19 in China. Engineering (Beijing) 6(10):1076–1084. https://doi.org/10.1016/j.eng.2020.10.003 CrossRef

37.

Haifeng C (2020) Interim measures for prevention and control of pneumonia of new coronavirus infection in Wuhan. http://www.chinanews.com/gn/2020/01-30/9073042.shtml. Accessed 20 August 2021

38.

Health Commission of Hubei Province (2020) The 104th press conference on the prevention and control of novel coronavirus pneumonia epidemic. 2020 http://wjw.hubei.gov.cn/bmdt/ztzl/fkxxgzbdgrfyyq/xxfb/202006/t20200603_2376649.shtml. Accessed 20 August 2021

39.

Shen J, Duan H, Zhang B et al (2020) Prevention and control of COVID-19 in public transportation: experience from China. Environ Pollut 266(Pt 2):115291. https://doi.org/10.1016/j.envpol.2020.115291 CrossRef

40.

CCTV New (2020) National Health Commission: high risk groups and high-risk groups will be given priority to vaccinate COVID-19 vaccine. https://baijiahao.baidu.com/s?id=1681057433403193310&wfr=spider&for=pc. Accessed 20 August 2021

41.

Miao Q, Schwarz S, Schwarz G (2020) Responding to COVID-19: community volunteerism and coproduction in China. World Dev 137:105128. https://doi.org/10.1016/j.worlddev.2020.105128 CrossRef

42.

Nanshan Zhong (2021) Guangzhou summed up five experiences in dealing with SARS-CoV-2 variant Delta for the first time. https://m.thepaper.cn/baijiahao_13322445. Accessed 20 August 2021

43.

State Council of the PRC (2020) Guiding opinions on COVID-19 prevention and control work in the area of scientific prevention and control of precise policies. http://www.gov.cn/xinwen/2020-02/18/content_5480514.htm. Accessed 20 August 2021

44.

State Council of the PRC (2020) Notice on strengthening community prevention and control of pneumonia epidemic of new coronavirus infection. http://www.gov.cn/xinwen/2020-01/27/content_5472481.htm. Accessed 20 August 2021

45.

The People's Govemment of Guangzhou Municipality (2020) Circular of Guangzhou headquarters for prevention and control of pneumonia epidemic caused by novel coronavirus infections on further strengthening community and rural epidemic prevention and control (no. 3). http://www.gz.gov.cn/xw/tzgg/content/post_5655563.html. Accessed 20 August 2021

46.

Department of Primary Healthcare of the PRC (2020) Primary healthcare institutions’ key role in epidemic control. http://www.nhc.gov.cn/jws/s3578/202002/19c2e477e8c04e20b76730daeb1296f8.shtml. Accessed 20 August 2021

47.

Sina News (2020) Guangdong People’s Hospital enables 5G infrared temperature measurement with accuracy to ± 0.2 degrees Celsius. http://news.sina.com.cn/s/2020-02-06/doc-iimxxste9254472.shtml. Accessed 20 August 2021

48.

Hangzhou Daily (2020) The nation’s first 5G medical temperature patrol robot came to work in Zhejiang Province. http://www.hangzhou.gov.cn/art/2020/2/7/art_812262_41886452.html. Accessed 20 August 2021

49.

China Daily (2020) Guangxi’s first 5G thermal imaging temperature measuring device put into use in Qinzhou. http://ex.chinadaily.com.cn/exchange/partners/82/rss/channel/cn/columns/80x78w/stories/WS5e3d0e93a3107bb6b579dd2b.html. Accessed 20 August 2021

50.

He D, Gu Y, Shi Y, Wang M, Lou Z, Jin C (2020) COVID-19 in China: the role and activities of Internet-based healthcare platforms. Glob Health Med 2(2):89–95. https://doi.org/10.35772/ghm.2020.01017 CrossRef

51.

China National Health Commission (2020) Notice of the General Office of the National Health Commission on internet diagnosis and treatment consulting services in epidemic prevention and control. http://www.nhc.gov.cn/yzygj/s7653p/202002/ec5e345814e744398c2adef17b657fb8.shtml . Accessed 20 August 2021

52.

Gong K, Xu Z, Cai Z, Chen Y, Wang Z (2020) Internet hospitals help prevent and control the epidemic of COVID-19 in China: multicenter user profiling study. J Med Internet Res 22(4):e18908. https://doi.org/10.2196/18908 CrossRef

53.

Zanin M, Xiao C, Liang T, Ling S, Zhao F, Huang Z, Lin F, Lin X, Jiang Z, Wong SS (2020) The public health response to the COVID-19 outbreak in mainland China: a narrative review. J Thorac Dis 12(8):4434–4449. https://doi.org/10.21037/jtd-20-2363 CrossRef

54.

Fan S, Wu M, Ma S, Zhao S (2020) A preventive and control strategy for COVID-19 infection: an experience from a third-tier Chinese city. Front Public Health 8:562024. https://doi.org/10.3389/fpubh.2020.562024 CrossRef

55.

Yang X, Chen X, Ding C, Bai Z, Zhu J, Sun G, Yu G (2020) Epidemiological investigation and prevention control analysis of the longitudinal distribution of COVID-19 in Henan Province. China mSphere 5(5):e00867-e920. https://doi.org/10.1128/mSphere.00867-20 CrossRef

56.

Lancet T (2020) Sustaining containment of COVID-19 in China. Lancet 395(10232):1230. https://doi.org/10.1016/S0140-6736(20)30864-3 CrossRef

57.

Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, Huang J, He N, Yu H, Lin X, Wei S, Wu T (2020) Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan. China JAMA 323(19):1915–1923. https://doi.org/10.1001/jama.2020.6130 CrossRef

58.

Zhong N, Zeng G (2006) What we have learnt from SARS epidemics in China. BMJ 333(7564):389–391. https://doi.org/10.1136/bmj.333.7564.389 CrossRef

59.

Enserink M (2003) SARS in China. China’s missed chance Science 301(5631):294–296. https://doi.org/10.1126/science.301.5631.294 CrossRef

60.

Xinhua News Agency (2020) Use big data to strengthen accurate measures for epidemic prevention and control. http://www.gov.cn/xinwen/2020-01/27/content_5472436.htm. Accessed 20 August 2021

61.

State Administration of Science, Technology and Industry for National Defence, PRC (2020) The close contact meter of COVID-19 patients has been launched. http://www.sastind.gov.cn/n112/n117/c6808819/content.html. Accessed 20 August 2021

62.

Ministry of Health (2003) Measures for prevention and control of infectious SARS. http://www.gov.cn/banshi/2005-08/01/content_19099.htm. Accessed 20 August 2021

63.

Lazarus JV, Ratzan S, Palayew A et al (2020) COVID-SCORE: a global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10). PLoS One 15(10):e0240011. https://doi.org/10.1371/journal.pone.0240011 CrossRef

64.

Blackbox Corp (2020) World in Crisis Global News Coverage. https://blackbox.com.sg/?news-feature=world-in-crisis-gloabal-news-coverage. Accessed 20 August 2021

65.

Song W (2020) China’s global engagement to fight the novel coronavirus pandemic. Glob Health Res Policy 5:44. https://doi.org/10.1186/s41256-020-00172-1 CrossRef

66.

Jin H, Lu L, Liu J, Cui M (2021) COVID-19 emergencies around the globe: China’s experience in controlling COVID-19 and lessons learned. Int J Qual Health Care 33(1):mzaa143. https://doi.org/10.1093/intqhc/mzaa143

67.

Zhou Q (2020) International collaboration for global accessibility of COVID-19 vaccines. Natl Sci Rev 7(8):1269. https://doi.org/10.1093/nsr/nwaa147 CrossRef

68.

Xinhua Net (2020) China shares genetic sequence of novel coronavirus from Wuhan: WHO. http://www.xinhuanet.com/english/2020-01/13/c_138700521.htm. Accessed 20 August 2021

69.

Wang D, Mao Z (2021) A comparative study of public health and social measures of COVID-19 advocated in different countries. Health Policy 125(8):957-971. https://doi.org/10.1016/j.healthpol.2021.05.016

Title: Public Health Measures and the Control of COVID-19 in China
Authors: Zhangkai Jason Cheng
Zhiqing Zhan
Mingshan Xue
Peiyan Zheng
Jiali Lyu
Jing Ma
Xiaohua Douglas Zhang
Wenting Luo
Huimin Huang
Yong Zhang
Hongman Wang
Nanshan Zhong
Baoqing Sun
Publication date: 18-09-2021
Publisher: Springer US
Keywords: Public Health
COVID-19
Published in: Clinical Reviews in Allergy & Immunology / Issue 1/2023
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-021-08900-2

Webinar | 08-11-2023 | 18:00 (CET)

Keynote Webinar | Spotlight on Diet and Diabetes

Watch now

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.

Prof. Mike Lean

Prof. Falko Sniehotta

Keynote Webinar | Spotlight on Diet and Diabetes

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy

A Review of Persistent Post-COVID Syndrome (PPCS)

Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis

Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality

Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement

Keynote Webinar | Spotlight on Diet and Diabetes